Premium
VolitionRX Limited (VNRX)
AMEX
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | Mr. Gael ForterreChief Commercial Officer | -262,55 | 997,69 | Sale to Issuer | 3,80 | 7,41k | -3,42% |
| 2026-03-17 | Mr. Rodney Gerard RootsaertCorporate Secretary | -197,40 | 750,12 | Sale to Issuer | 3,80 | 6,32k | -3,03% |
| 2026-03-17 | Mr. Nicholas PlummerGroup General Counsel | -350,15 | 1,33k | Sale to Issuer | 3,80 | 8,75k | -3,85% |
| 2026-03-17 | Dr. Jacob Vincent MicallefChief Scientific Officer | -265,50 | 1,01k | Sale to Issuer | 3,80 | 22,11k | -1,19% |
| 2026-03-01 | Mr. Rodney Gerard RootsaertCorporate Secretary | -166,05 | 707,37 | Sale to Issuer | 4,26 | 6,04k | -2,67% |
| 2026-03-01 | Mr. Gael ForterreChief Commercial Officer | -114,15 | 486,28 | Sale to Issuer | 4,26 | 7,04k | -1,60% |
| 2026-03-01 | Mr. Nicholas PlummerGroup General Counsel | -293,35 | 1,25k | Sale to Issuer | 4,26 | 8,35k | -3,39% |
| 2026-02-01 | Mr. Gael ForterreChief Commercial Officer | -100,50 | 572,85 | Sale to Issuer | 5,70 | 8,50k | -1,17% |
| 2026-02-01 | Mr. Rodney Gerard RootsaertCorporate Secretary | -159,80 | 910,86 | Sale to Issuer | 5,70 | 5,81k | -2,68% |
| 2026-02-01 | Mr. Nicholas PlummerGroup General Counsel | -282,35 | 1,61k | Sale to Issuer | 5,70 | 8,02k | -3,40% |
| 2025-11-17 | Mr. Cameron ReynoldsFounder, CEO, President & Director | 1 000,00 | 7,00k | Achat | 7,00 | 98,12k | 1,03% |
| 2025-11-01 | Dr. Andrew RetterInitié | -229,40 | 1,99k | Sale to Issuer | 8,68 | 3,00k | -7,10% |
| 2025-11-01 | Mr. Nicholas PlummerGroup General Counsel | -282,35 | 2,45k | Sale to Issuer | 8,68 | 4,87k | -5,48% |
| 2025-11-01 | Mr. Rodney Gerard RootsaertCorporate Secretary | -159,85 | 1,39k | Sale to Issuer | 8,68 | 5,59k | -2,78% |
| 2025-11-01 | Dr. Salvatore Thomas ButeraInitié | -232,40 | 2,02k | Sale to Issuer | 8,68 | 17,57k | -1,31% |
| 2025-11-01 | Mr. Gael ForterreChief Commercial Officer | -87,65 | 760,80 | Sale to Issuer | 8,68 | 8,36k | -1,04% |
| 2025-10-14 | Mr. Cameron ReynoldsFounder, CEO, President & Director | 5,50k | 56,10k | Achat | 10,20 | 94,31k | 6,19% |
| 2025-10-14 | Mr. Guy Archibald InnesLead Independent Director | 4,81k | 49,04k | Achat | 10,20 | 147,28k | 3,37% |
| 2025-10-14 | Mr. Cameron ReynoldsFounder, CEO, President & Director | 5,50k | 0,00 | Open Market Derivative Acquisition | 12,00 | 5,50k | - |
| 2025-10-14 | Mr. Guy Archibald InnesLead Independent Director | 4,81k | 0,00 | Open Market Derivative Acquisition | 12,00 | 4,81k | - |
| 2025-10-14 | Mr. Timothy I. StillIndependent Chairman | 2,40k | 24,52k | Achat | 10,20 | 6,77k | 55,02% |
| 2025-10-14 | Mr. Timothy I. StillIndependent Chairman | 2,40k | 0,00 | Open Market Derivative Acquisition | 12,00 | 2,40k | - |
| 2025-10-04 | Dr. Salvatore Thomas ButeraInitié | -291,70 | 3,78k | Sale to Issuer | 12,96 | 16,95k | -1,69% |
| 2025-10-04 | Ms. Louise Batchelor DayGroup Chief Marketing & Communications Officer | -305,50 | 3,96k | Sale to Issuer | 12,96 | 5,62k | -5,16% |
| 2025-10-04 | Mr. Rodney Gerard RootsaertCorporate Secretary | -231,00 | 2,99k | Sale to Issuer | 12,96 | 5,37k | -4,12% |
| 2025-10-04 | Mr. Gael ForterreChief Commercial Officer | -269,45 | 3,49k | Sale to Issuer | 12,96 | 8,20k | -3,18% |
| 2025-10-04 | Dr. Gaetan MichelCOO | -616,65 | 7,99k | Sale to Issuer | 12,96 | 6,70k | -8,43% |
| 2025-10-04 | Mr. Nicholas PlummerGroup General Counsel | -407,30 | 5,28k | Sale to Issuer | 12,96 | 7,39k | -5,23% |
| 2025-10-04 | Dr. Jacob Vincent MicallefChief Scientific Officer | -292,50 | 3,79k | Sale to Issuer | 12,96 | 21,79k | -1,32% |
| 2025-09-28 | Dr. Salvatore Thomas ButeraInitié | -261,50 | 3,16k | Sale to Issuer | 12,10 | 16,89k | -1,52% |
| 2025-09-28 | Mr. Rodney Gerard RootsaertCorporate Secretary | -207,90 | 2,52k | Sale to Issuer | 12,10 | 5,05k | -3,95% |
| 2025-09-28 | Dr. Jacob Vincent MicallefChief Scientific Officer | -278,40 | 3,37k | Sale to Issuer | 12,10 | 21,38k | -1,29% |
| 2025-09-28 | Ms. Louise Batchelor DayGroup Chief Marketing & Communications Officer | -280,20 | 3,39k | Sale to Issuer | 12,10 | 5,86k | -4,57% |
| 2025-09-28 | Dr. Gaetan MichelCOO | -568,10 | 6,87k | Sale to Issuer | 12,10 | 3,72k | -13,26% |
| 2025-09-28 | Mr. Gael ForterreChief Commercial Officer | -275,15 | 3,33k | Sale to Issuer | 12,10 | 7,70k | -3,45% |
| 2025-09-12 | Mr. Cameron ReynoldsFounder, CEO, President & Director | 750,00 | 9,89k | Achat | 13,18 | 98,81k | 0,76% |
| 2025-08-05 | Mr. Guy Archibald InnesLead Independent Director | 3,91k | 50,00k | Achat | 12,80 | 142,47k | 2,82% |
| 2025-08-05 | Mr. Cameron ReynoldsFounder, CEO, President & Director | 3,91k | 50,00k | Achat | 12,80 | 98,06k | 4,15% |
| 2025-08-01 | Dr. Andrew RetterInitié | -307,10 | 3,93k | Sale to Issuer | 12,80 | 2,74k | -10,08% |
| 2025-08-01 | Dr. Salvatore Thomas ButeraInitié | -319,65 | 4,09k | Sale to Issuer | 12,80 | 15,48k | -2,02% |
| 2025-08-01 | Ms. Louise Batchelor DayGroup Chief Marketing & Communications Officer | -431,00 | 5,52k | Sale to Issuer | 12,80 | 4,83k | -8,19% |
| 2025-08-01 | Mr. Gael ForterreChief Commercial Officer | -138,30 | 1,77k | Sale to Issuer | 12,80 | 7,30k | -1,86% |
| 2025-08-01 | Mr. Nicholas PlummerGroup General Counsel | -222,55 | 2,85k | Sale to Issuer | 12,80 | 4,09k | -5,16% |
| 2025-08-01 | Mr. Rodney Gerard RootsaertCorporate Secretary | -213,95 | 2,74k | Sale to Issuer | 12,80 | 4,77k | -4,30% |
| 2025-07-01 | Ms. Louise Batchelor DayGroup Chief Marketing & Communications Officer | -308,85 | 4,74k | Sale to Issuer | 15,36 | 4,47k | -6,46% |
| 2025-06-01 | Mr. Gael ForterreChief Commercial Officer | -99,80 | 1,53k | Sale to Issuer | 15,36 | 7,62k | -1,29% |
| 2025-07-01 | Mr. Nicholas PlummerGroup General Counsel | -270,85 | 4,16k | Sale to Issuer | 15,36 | 3,51k | -7,16% |
| 2025-07-01 | Mr. Rodney Gerard RootsaertCorporate Secretary | -153,30 | 2,35k | Sale to Issuer | 15,36 | 4,47k | -3,32% |
| 2025-07-01 | Dr. Salvatore Thomas ButeraInitié | -223,10 | 3,43k | Sale to Issuer | 15,36 | 14,63k | -1,50% |
| 2025-07-01 | Dr. Andrew RetterInitié | -220,05 | 3,38k | Sale to Issuer | 15,36 | 2,40k | -8,41% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
